U.S. markets open in 6 hours 8 minutes

Lifeloc Technologies, Inc. (LCTC)

Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
3.4100+0.0400 (+1.19%)
At close: 10:18AM EDT
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Previous Close3.3700
Open3.4100
Bid0.0000 x 0
Ask0.0000 x 0
Day's Range3.4100 - 3.4100
52 Week Range1.5000 - 4.9200
Volume250
Avg. Volume470
Market Cap8.27M
Beta (5Y Monthly)1.50
PE Ratio (TTM)N/A
EPS (TTM)-0.3800
Earnings DateMar 30, 2021
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
N/A
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
View more
  • Lifeloc Reports 2020 Full Year Results
    PR Newswire

    Lifeloc Reports 2020 Full Year Results

    Lifeloc Technologies, Inc. (OTC: LCTC), a global leader in the development and manufacturing of breath alcohol testing devices, has announced financial results for the 2020 fiscal year ended December 31, 2020.

  • Lifeloc Reports Third Quarter 2020 Results
    PR Newswire

    Lifeloc Reports Third Quarter 2020 Results

    Lifeloc Technologies, Inc. (OTC: LCTC), a global leader in the development and manufacturing of breath alcohol and drug testing devices, has announced financial results for the third quarter and for the nine months ended September 30, 2020.

  • Lifeloc Reports Second Quarter 2020 Results
    PR Newswire

    Lifeloc Reports Second Quarter 2020 Results

    Lifeloc Technologies, Inc. (OTC: LCTC), a global leader in the development and manufacturing of breath alcohol and drug testing devices, has announced financial results for the second quarter and for the six months ended June 30, 2020.